Evidence into practice: moving forward with anti-IgE

M. Humbert (Clamart, France)

Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Session: Changing practice with anti-IgE: patient, physician and payor perspectives
Session type: Evening Symposium
Number: 2846

Multimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Humbert (Clamart, France). Evidence into practice: moving forward with anti-IgE. Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Telemonitoring in clinical practice: a way forward?
Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice"
Year: 2013


Moving forward from drug-centred to patient-centred research
Source: Eur Respir J, 53 (2) 1801870; 10.1183/13993003.01870-2018
Year: 2019



Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?
Source: Eur Respir J 2004; 23: 793-794
Year: 2004


Is our approach to basic research right? Pitfalls and successes: what is the way forward?
Source: ERS Research Seminar 2016
Year: 2016

Anti-IgE therapy: current knowledge and future perspective
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward
Source: Eur Respir J 2013; 42: 1446-1448
Year: 2013


Anti-IgE: changing lives in clinical practice?
Source: Eur Respir Rev 2007; 16: 59-60
Year: 2007


Personalised medicine: a step forward to better care?
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013



Omalizumab in practice: learning from experience
Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Year: 2007

Evaluating response to omalizumab (anti-IgE) in clinical practice
Source: Eur Respir J 2005; 26: Suppl. 49, 48s
Year: 2005

Nurse prescribing in COPD - The way forward
Source: Eur Respir J 2002; 20: Suppl. 38, 621s
Year: 2002

EASE: major outcomes and lessons going forward
Source: Annual Congress 2010 - Clinical Trials: "EURO VENT - endobronchial valves in heterogeneous emphysema patients", "EASE - randomized trial of airway bypass in homogeneous emphysema"
Year: 2010


The way forward: how to link real-life situations and clinical trial results
Source: Annual Congress 2013 - Lunchtime Session "Tiotropium soft mist inhaler and mortality in COPD: results of the TIOSPIR clinical trial"
Year: 2013

Current practice and future directions in CSA treatment: positive airway pressure, stimulation and pharmacotherapy
Source: Sleep and Breathing Conference 2021
Year: 2021


Eosinophils are out of fashion: the only way forward is to target the neutrophils
Source: International Congress 2016 – Childhood wheeze: are we making any progress?
Year: 2016